Background illustration for clinical trials search

Paid Clinical Trials Riverside

Discover 3,005 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

for
Hemophilia A
Location: Orange CA, San Francisco CA, Vallejo CA, Newark NJ,
Sponsor: Hoffmann-La Roche

Sex: Male

Age: 18+

Code: NCT07226206

Phase 1, Phase 2, Recruiting
Featured

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

for
Atherosclerosis
Location: Irvine CA, Beverly Hills CA, Los Angeles CA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07448038

Phase 2, Recruiting
Featured

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Orange CA, Los Angeles CA, Sacramento CA, Houston TX,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT04302025

Phase 2, Recruiting
Featured

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

for
Breast Cancer
Location: Orange CA, Los Angeles CA, Vancouver, Germantown TN,
Sponsor: Hoffmann-La Roche

Sex: Female

Age: 18+

Code: NCT07054190

Phase 2, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Fullerton CA, Pasadena CA, Los Angeles CA, La Jolla CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

for
Non Small Cell Lung Carcinoma, c-MET
Location: Fullerton CA, Santa Monica CA, Oxnard CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06772623

Phase 1, Phase 2, Recruiting
Featured

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Fullerton CA, Glendale CA, Torrance CA, Los Angeles CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Fullerton CA, Los Angeles CA, Portland OR,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase 2, Recruiting
Featured

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

for
Chronic Migraine
Location: Anaheim CA, Long Beach CA, Oceanside CA, Fresno CA,
Sponsor: AbbVie

Sex: All

Age: 12 - 17

Code: NCT06810505

Phase 3, Recruiting
Featured

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Anaheim CA, La Palma CA, Oceanside CA, Winnetka CA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting
Featured

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

for
Episodic Migraine
Location: Anaheim CA, Long Beach CA, San Jose CA, Walnut Creek CA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05711394

Phase 3, Recruiting
Featured

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

for
Breast Cancer
Location: Anaheim CA, Palo Alto CA, Pierre SD, Mitchell SD,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07405801

Phase 2, Recruiting
Featured

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

for
Alzheimer's Disease
Location: Irvine CA, Boulder CO, Dallas TX, Cordova TN,
Sponsor: AbbVie

Sex: All

Age: 50 - 70+

Code: NCT07599670

Phase 1, Phase 2, Recruiting
Featured

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

for
Migraine
Location: Aliso Viejo CA, Grand Island NE, Naperville IL
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07310290

Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Irvine CA, Orange CA, Newport Beach CA, Los Angeles CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting
Featured

A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants

for
Healthy Volunteers
Location: Anaheim CA, Grayslake IL
Sponsor: AbbVie

Sex: All

Age: 18 - 55

Code: NCT07673120

Phase 1, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

for
Obesity or Overweight
Location: Irvine CA, San Diego CA, Walnut Creek CA, Tucson AZ,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351045

Phase 3, Recruiting
Featured

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: Duarte CA, Santa Monica CA, Seattle WA, Austin TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06820463

Phase 2, Recruiting
Featured

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

for
Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma,
Location: Duarte CA, San Francisco CA, San Antonio TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06084481

Phase 1, Recruiting
Featured

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

for
Lymphoma
Location: Duarte CA, Los Angeles CA, Santa Monica CA, Reno NV,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06084936

Phase 3, Recruiting